The need for more and better quality data on medication safety in human pregnancy has been in the public and regulatory spotlight for decades. The issue is becoming even more urgent with the...
The last decade has brought much attention to the risks of fetal exposure to antidepressant medications, with numerous studies describing the risks of adverse outcomes that range from congenital...
It is estimated that 30%-70% of children diagnosed with attention-deficit/hyperactivity disorder will continue to experience symptoms as they grow older. The prevalence of the disorder in adults is...
Up to 80% of women experience morning sickness, and about 25% of them continue to experience symptoms through the second and third trimesters. The delayed-release combination of the antihistamine...